XML 78 R66.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Revenue $ 5,175 $ 26,082 $ 39,143 $ 54,293
Significant segment expenses        
Loss from operations 172,202 98,354 539,798 295,236
Other non-operating income (loss), net 9,952 2,679 3,005 9,347
Income tax benefit (expense) (3) (167) 156 1,134
Total segment loss 162,253 95,842 536,637 284,755
Reportable Segment        
Segment Reporting Information [Line Items]        
Revenue 5,175 26,082 39,143 54,293
Significant segment expenses        
Salaries 68,600 55,515 235,190 156,171
Consumables 8,928 19,419 92,725 54,176
Platform 14,377 8,330 36,934 13,102
Discovery 37,049 3,375 58,716 19,115
Clinical development 10,814 9,050 33,338 31,966
Depreciation and amortization 18,708 6,637 64,223 22,982
Other segment items 18,901 22,110 57,815 52,017
Loss from operations 172,202 98,354 539,798 295,236
Other non-operating income (loss), net 9,952 2,679 3,005 9,347
Income tax benefit (expense) (3) (167) 156 1,134
Total segment loss 162,253 95,842 536,637 284,755
Supplemental asset information        
Total expenditures for additions to long-lived assets $ 39 $ 4,248 $ 5,283 $ 12,633